Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.8M Sell
16,400
-33,000
-67% -$10.8M 0.01% 1673
2025
Q4
$17.3M Sell
49,400
-4,100
-8% -$1.39M 0.02% 991
2025
Q3
$17.3M Buy
53,500
+13,400
+33% +$4.17M 0.02% 971
2025
Q2
$15.6M Buy
40,100
+27,900
+229% +$11.2M 0.02% 1023
2025
Q1
$5.31M Buy
12,200
+7,100
+139% +$2.85M 0.01% 1489
2024
Q4
$1.88M Hold
5,100
﹤0.01% 1899
2024
Q3
$2.65M Buy
5,100
+4,600
+920% +$2.46M ﹤0.01% 1661
2024
Q2
$271K Buy
+500
New +$264K ﹤0.01% 2343

Other funds holding ELV

Qube Research & Technologies (QRT)'s ELV Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Elevance Health (ELV) in Q1 2026: 112,717 shares worth $33M. The stake represents 0.04% of the portfolio and ranks #610 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ELV as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 25 quarters since. The position peaked at $227M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Qube Research & Technologies (QRT) held 112,717 shares of Elevance Health worth $33M as of Q1 2026.
  • Elevance Health was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Elevance Health made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #610 holding.
  • Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 25 quarters since.
  • Qube Research & Technologies (QRT)'s Elevance Health position peaked at $227M in Q1 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.